Literature DB >> 1719074

Pertussis toxin prevents the induction of peripheral T cell anergy and enhances the T cell response to an encephalitogenic peptide of myelin basic protein.

T Kamradt1, P D Soloway, D L Perkins, M L Gefter.   

Abstract

In a murine model of T cell-mediated autoimmune disease, experimental autoimmune encephalitis (EAE), 80% of all encephalitogenic T cell clones in H-2u mice use the V beta 8.2 TCR element. To induce EAE in susceptible strains of mice either heat-killed Bordetella pertussis organisms or Bordetella pertussis toxin (PT) must be injected in addition to Ag in CFA. We investigated the mechanisms by which PT facilitates the induction of EAE. Our data show, that PT interferes with the induction of Ag-induced peripheral T cell anergy. Furthermore it has a specific adjuvanticity for the autoantigen pAc1-11 in vivo and acts as a selective mitogen in vitro. We also tested the hypothesis that PT is a bacterial superantigen that specifically expands the V beta 8.2+ subset of T cells, thereby expanding the encephalitogenic T cell clones that are contained in this subset, so that the number of autoreactive T cells is brought over a critical threshold, necessary to induce autoimmune disease. Our data show that PT is not a superantigen. Staphylococcal enterotoxin B, a V beta 8.2-specific superantigen, does not enhance the immune response to the encephalitogenic peptide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719074

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.

Authors:  B Laliotou; J Liversidge; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

2.  Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in alphabeta T-cell receptor transgenic mice.

Authors:  C Infante-Duarte; T Kamradt
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 3.  A role for T cells in the pathogenesis of treatment-resistant Lyme arthritis.

Authors:  T Kamradt; A Krause; G R Burmester
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

4.  Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

Authors:  M K Racke; D E Scott; L Quigley; G S Gray; R Abe; C H June; P J Perrin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis.

Authors:  J Schiffenbauer; H M Johnson; E J Butfiloski; L Wegrzyn; J M Soos
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 6.  Modeling multiple sclerosis in laboratory animals.

Authors:  Bettina Schreiner; Frank L Heppner; Burkhard Becher
Journal:  Semin Immunopathol       Date:  2009-10-03       Impact factor: 9.623

7.  Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.

Authors:  Petra D Cravens; Rehana Z Hussain; Tresa E Zacharias; Li-Hong Ben; Emily Herndon; Ramya Vinnakota; Doris Lambracht-Washington; Stefan Nessler; Scott S Zamvil; Todd N Eagar; Olaf Stüve
Journal:  J Neuroinflammation       Date:  2011-06-24       Impact factor: 8.322

Review 8.  Multiple sclerosis: experimental models and reality.

Authors:  Hans Lassmann; Monika Bradl
Journal:  Acta Neuropathol       Date:  2016-10-20       Impact factor: 17.088

Review 9.  Gender and sex hormones in multiple sclerosis pathology and therapy.

Authors:  Arnaud Nicot
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.

Authors:  B Lengl-Janssen; A F Strauss; A C Steere; T Kamradt
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.